Results 181 to 190 of about 197,714 (301)
Epidemiology changes in systemic lupus erythematosus in Italy: the EASIEST study. [PDF]
Gasparotto M +16 more
europepmc +1 more source
T cells, the Next Big Target in Axial Spondyloarthritis?
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review, we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells. We highlight
Mansi K. Aparnathi, Nigil Haroon
wiley +1 more source
The landscape of cellular immune alteration in systemic lupus erythematosus. [PDF]
Xiao J +11 more
europepmc +1 more source
Objective Hydroxychloroquine (HCQ) nonadherence in systemic lupus erythematosus (SLE) stemming from decision complexities can be improved with shared decision‐making (SDM) tools clarifying benefits and harms. This study aimed to develop and evaluate HCQ‐SAFE, a pictogram‐based SDM tool during SLE visits.
Caroline Packee +8 more
wiley +1 more source
Late-Onset Systemic Lupus Erythematosus: Is It Really a Benign Disease? [PDF]
Santacruz JC +6 more
europepmc +1 more source
Objective The aim of this study was to investigate whether exposure to mixture of individual fine particulate matter (PM2.5) chemical constituents is associated with incident systemic lupus erythematosus (SLE) and if ozone modifies this association and/or is associated with SLE onset.
Naizhuo Zhao +9 more
wiley +1 more source
A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus. [PDF]
Renaudineau Y +12 more
europepmc +1 more source
Systemic Lupus Erythematosus [PDF]
openaire +2 more sources
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia +16 more
wiley +1 more source
Performance of common fetal growth standards in pregnancies affected by systemic lupus erythematosus. [PDF]
Barros ACRP +6 more
europepmc +1 more source

